CoChat

Bone and metabolic health in patients with non‐metastatic prostate cancer who are receiving androgen deprivation therapy

Open access
Grossmann, Mathis, Hamilton, Emma J, Gilfillan, Christopher, Bolton, Damien, Joon, Daryl Lim, Zajac, Jeffrey D · 2011 · Medical Journal of Australia
Cited by 104

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

Androgen deprivation therapy (ADT) in men with prostate cancer increases the risk of osteoporotic fractures, type 2 diabetes and, possibly, cardiovascular events. There is considerable uncertainty about the risk-benefit ratio of ADT in non-palliative treatment; the benefits of ADT in treating non-metastatic prostate cancer need to be carefully weighed against the risks of ADT-induced adverse events. Baseline assessment of bone health at the initiation of ADT should include measurement of bone mineral density (BMD) by dual energy x-ray absorptiometry and, in men with osteopaenia, a thoracolumbar spine x-ray. General measures to prevent bone loss, including regular physical activity, as well as ensuring calcium and vitamin D sufficiency, should be instituted routinely. All men with a previous minimal trauma fracture should receive pharmacological therapy unless contraindicated; for those who have not sustained a minimal trauma fracture, treatment is advised if the BMD T score is ≤ - 2.0, or if the 10-year risk of a major osteoporotic fracture exceeds 20%. Men with prostate cancer who are receiving ADT should be closely monitored for weight gain and diabetes; intensive lifestyle intervention is recommended to prevent ADT-induced weight gain and insulin resistance. Management of the metabolic sequelae of ADT includes optimal reduction of cardiovascular risk factors, with particular attention to weight, blood pressure, lipid profile, smoking cessation, and glycaemic control.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.5694/j.1326-5377.2011.tb02979.x

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Cited by

See all 104

Metadata

Authors
Grossmann, M., Hamilton, E. J., Gilfillan, C., Bolton, D., Joon, D. L., & Zajac, J. D.
Venue
Medical Journal of Australia
Publisher
Wiley
Published
2011-03
Volume
194
Issue
6
Pages
301-306
ISSN
  • 0025-729X (ISSN-L)
  • 1326-5377
OpenAlex
W1445129496
Cited by
104
References
10
FWCI
10.40
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Bone and metabolic health in patients with non‐metastatic prostate cancer who are receiving androgen deprivation therapy. https://app.cochat.ai/papers/10.5694/j.1326-5377.2011.tb02979.x
The paper
Grossmann, M., Hamilton, E. J., Gilfillan, C., Bolton, D., Joon, D. L., & Zajac, J. D. (2011). Bone and metabolic health in patients with non‐metastatic prostate cancer who are receiving androgen deprivation therapy. Medical Journal of Australia. https://doi.org/10.5694/j.1326-5377.2011.tb02979.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.